Status:
RECRUITING
Cord Blood Preptin Levels in Infants
Lead Sponsor:
Konya City Hospital
Conditions:
Newborn Morbidity
Newborn Complication
Eligibility:
All Genders
1-5 years
Phase:
NA
Brief Summary
In this study, cord blood preptin levels in infants with high or low birth weight will be compared to those in infants with normal birth weight. Our aim is to determine whether there is a relationship...
Detailed Description
Preptin is the youngest identified member of the insulin family. It is a 34-amino acid protein derived from the E-peptide of pro-insulin-like growth factor 2. Preptin was first isolated in 2001 from t...
Eligibility Criteria
Inclusion
- Large-for-Gestational-Age (LGA) Infants
- Appropriate-for-Gestational-Age (AGA) Infants
- Small-for-Gestational-Age (SGA) Infants
- Infants of Diabetic Mothers (IDM)
Exclusion
- Infants with a syndromic appearance or any accompanying disease
- Infants whose families did not provide consent
Key Trial Info
Start Date :
March 10 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2025
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06880003
Start Date
March 10 2025
End Date
November 1 2025
Last Update
March 20 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Melek Buyukeren
Konya, Karatay, Turkey (Türkiye), 42020